183 related articles for article (PubMed ID: 27104516)
1. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis.
Lee CH; Chen SL; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chiou YH; Chen CY; Lin CY; Chen ML; Chen CJ
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104516
[TBL] [Abstract][Full Text] [Related]
2. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
[TBL] [Abstract][Full Text] [Related]
3. High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients.
Sung WW; Lin YM; Wu PR; Yen HH; Lai HW; Su TC; Huang RH; Wen CK; Chen CY; Chen CJ; Yeh KT
BMC Cancer; 2014 Dec; 14():951. PubMed ID: 25511643
[TBL] [Abstract][Full Text] [Related]
4. Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer.
Nakamura H; Takada K; Arihara Y; Hayasaka N; Murase K; Iyama S; Kobune M; Miyanishi K; Kato J
Cancer Gene Ther; 2019 Sep; 26(9-10):313-322. PubMed ID: 30401882
[TBL] [Abstract][Full Text] [Related]
5. A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.
Zhang Z; Hou WB; Zhang C; Tan YE; Zhang DD; An W; Pan SW; Wu WD; Chen QC; Xu HM
J Cell Mol Med; 2020 Dec; 24(24):14217-14230. PubMed ID: 33128353
[TBL] [Abstract][Full Text] [Related]
6. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
7. Opposing prognostic roles of nuclear and cytoplasmic RACGAP1 expression in colorectal cancer patients.
Yeh CM; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chang WH; Chen CY; Ko JL; Chen CJ
Hum Pathol; 2016 Jan; 47(1):45-51. PubMed ID: 26508373
[TBL] [Abstract][Full Text] [Related]
8. STEAP1 is overexpressed in cancers: a promising therapeutic target.
Moreaux J; Kassambara A; Hose D; Klein B
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):148-55. PubMed ID: 23142226
[TBL] [Abstract][Full Text] [Related]
9. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.
Zhao C; Xiong K; Ji Z; Liu F; Li X
Oxid Med Cell Longev; 2022; 2022():8297011. PubMed ID: 35313641
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
[TBL] [Abstract][Full Text] [Related]
12. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
13. Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis.
Zhao S; Chen H; Zhou Y; Wang Q; Liang X; Yang N; Yan L; Yang J
Front Biosci (Landmark Ed); 2023 Nov; 28(11):280. PubMed ID: 38062846
[TBL] [Abstract][Full Text] [Related]
14. Expression of CHD5 may serve as an independent biomarker of prognosis in colorectal cancer via immunohistochemical staining.
Zhou Y; Qiu YE; Qin SL; Luo Y; Cui R; Qin J; Chen JJ; Yu MH; Zhong M; Shi XY
Int J Clin Exp Pathol; 2018; 11(5):2792-2798. PubMed ID: 31938397
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
16. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of STEAP1 extracellular vesicles in prostate cancer.
Khanna K; Salmond N; Lynn KS; Leong HS; Williams KC
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):802-811. PubMed ID: 33589770
[TBL] [Abstract][Full Text] [Related]
18. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer.
He J; Li J; Feng W; Chen L; Yang K
Int J Clin Exp Pathol; 2015; 8(12):16007-13. PubMed ID: 26884876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
